- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Multislice CT complements ultrasound in GI staging
While both multislice CT and endoscopic ultrasound can evaluate local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam. It thus provides superior staging of T3 and T4 cancers, according to a study presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
While both multislice CT and endoscopic ultrasound can evaluate local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam. It thus provides superior staging of T3 and T4 cancers, according to a study presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
Dr. Ahmed Ba-Ssalamah and colleagues at the Medical University of Vienna enrolled 23 patients with esophageal carcinoma. The patients underwent endoscopic sonography and contrast-enhanced MSCT using a gas-water GI-filling technique.
Endoscopic ultrasound and MSCT each provided 100% sensitivity for tumor detection, but the sensitivity of other end points varied. Ultrasound was favored for tumor staging (89% versus 79%) and for diagnosis of local node involvement (82% versus 76%). CT was better in diagnosing distant node involvement and other metastases (65% versus 92%).
MSCT offers a field-of-view depth superior to endoscopic ultrasound for staging and detection of local disease and distant lymph node metastases, but it isn't perfect. Differentiation between T1 and T2 stages using the bowel distention-plus contrast technique is difficult, if not impossible. And MSCT's spatial resolution is still inferior to endoscopic ultrasound.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
